AAV-Mediated Direct Somatic Genetic Correction of Epidermolysis Bullosa

被引：0
|
作者：
Melo, Sandra [1 ]
Lisowski, Leszek [2 ,3 ]
Bashkirova, Lisa [1 ]
Kay, Mark A. [2 ,3 ]
Oro, Anthony E. [1 ]
机构：
[1] Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA
来源：
MOLECULAR THERAPY | 2013年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
277
引用
收藏
页码：S106 / S106
页数：1
相关论文
共 50 条
  • [1] AAV-mediated somatic genetic correction of epidermolysis bullosa
    Melo, S. P.
    Lisowski, L.
    Bashkirova, L.
    Kay, M. A.
    Oro, A. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S139 - S139
  • [2] Somatic Correction of Junctional Epidermolysis Bullosa by a Highly Recombinogenic AAV Variant
    Melo, Sandra P.
    Lisowski, Leszek
    Bashkirova, Elizaveta
    Zhen, Hanson H.
    Chu, Kirk
    Keene, Douglas R.
    Marinkovich, M. Peter
    Kay, Mark A.
    Oro, Anthony E.
    MOLECULAR THERAPY, 2014, 22 (04) : 725 - 733
  • [3] Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors
    Baldeschi, C
    Gache, Y
    Rattenholl, A
    Bouillé, P
    Danos, O
    Ortonne, JP
    Bruckner-Tuderman, L
    Meneguzzi, G
    HUMAN MOLECULAR GENETICS, 2003, 12 (15) : 1897 - 1905
  • [4] Direct AAV-mediated gene delivery to the temporomandibular joint
    Dai, Juan
    Bakr, A.
    Rabie, M.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 2212 - 2220
  • [5] In Vivo Genetic Eye Disease Correction Using Split AAV-Mediated Adenine Base Editing
    Sullivan, Jack
    Muller, Alissa
    Schwarzer, Wibke
    Wang, Mantian
    Park-Windhol, Cindy
    Hasler, Pascal
    Moreau, Pierre-Henri
    Azoulay, Thierry
    Janeschitz-Kriegl, Lucas
    Szabo, Arnold
    Scholl, Hendrik P. N.
    Roska, Botond
    Gyorgy, Bence
    Bryson, David I.
    Ciaramella, Giuseppe
    MOLECULAR THERAPY, 2023, 31 (04) : 168 - 168
  • [6] φC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa
    Ortiz-Urda, S
    Thyagarajan, B
    Keene, DR
    Lin, Q
    Calos, MP
    Khavari, PA
    HUMAN GENE THERAPY, 2003, 14 (09) : 923 - 928
  • [7] AAV-mediated gene correction in a mutant transgenic LacZ mouse
    Dejneka, NS
    Igoucheva, O
    Alexeev, V
    Maguire, AM
    Pierce, EA
    Yoon, K
    Bennett, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U291 - U291
  • [8] Correction of bone and cartilage pathology and other somatic alterations by AAV-mediated gene therapy in a new rat model of Morquio A
    Bertolin, J.
    Jaen, M. L.
    Garcia, M.
    Sanchez, V.
    Munoz, S.
    Ribera, A.
    Sanchez, X.
    Marco, S.
    Perez, J.
    Elias, G.
    Leon, X.
    Navarro, M.
    Ruberte, J.
    Bosch, F.
    HUMAN GENE THERAPY, 2019, 30 (11) : A171 - A172
  • [9] AAV Integration Analysis after Long Term Follow Up in Hemophilia a Dogs Reveals the Genetic Consequences of AAV-Mediated Gene Correction
    Everett, John K.
    Nguyen, Giang N.
    Raymond, Hayley
    Roche, Aiofe
    Kafle, Samita
    Wood, Christian
    Leiby, Jacob
    Merricks, Elizabeth P.
    Kazazian, Haig H.
    Nichols, Timothy C.
    Bushman, Frederic D.
    Sabatino, Denise E.
    MOLECULAR THERAPY, 2020, 28 (04) : 409 - 409
  • [10] AAV-mediated modulation or direct injection of PEDF for the control of vascular retinopathy
    Raisler, BJ
    Martino, A
    Chiodo, V
    Hauswirth, WW
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U355 - U355
12345